---
title: "Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility"
description: |
  * **Objective**: This study used a two-sample Mendelian randomization (MR) and colocalization approach to identify genes whose **tissue-specific expression** is causally associated with the risk of **glioma** and its subtypes (glioblastoma and non-GBM gliomas).
  * **Key Findings**: MR analysis provided evidence for a causal link between the expression of **12 genes** and glioma risk, including three novel genes: **RETREG2/FAM134A**, **FAM178B**, and **MVB12B**.
  * **Tissue Specificity**: The results confirmed that effects are often **tissue-dependent**, such as the association for **MDM4** being specific to **brain tissue**, emphasizing the necessity of using relevant eQTL data.
date: last-modified
categories: [colocalization, eQTL, gene expression, glioblastoma, glioma, mendelian randomization, tissue specificity]
---

**PubMed:** [33504897](https://pubmed.ncbi.nlm.nih.gov/33504897/)
**DOI:** [10.1038/s41598-021-82169-5](https://doi.org/10.1038/s41598-021-82169-5)
**Overview generated by:** Gemini 2.5 Flash, 28/11/2025

## Key Findings: Identifying Glioma Susceptibility Genes

This study integrated genetic data and gene expression data using Mendelian randomization (MR) to identify genes whose expression levels in specific tissues are causally linked to **glioma susceptibility** and its subtypes (**glioblastoma (GBM)** and **non-GBM gliomas**).

* **Prioritized Causal Genes:** The combined MR and colocalization approach provided evidence that genetically predicted increased gene expression of **12 genes** is associated with an increased risk of glioma, GBM, and/or non-GBM risk.
* **Novel Susceptibility Genes:** Three of these 12 genes are **novel glioma susceptibility genes**: **RETREG2/FAM134A**, **FAM178B**, and **MVB12B**.
* **Tissue Dependence:** The findings demonstrated strong evidence for **tissue-dependent effects**. For example, the causal effect of **MDM4** expression on glioma risk was found to be specific to **brain tissue**, whereas effects for other genes (like **TP53**) were more generalized (present in both brain and whole blood).
* **Glioma Subtype Specificity:** The study observed distinct genetic associations for the different glioma subtypes, suggesting that some genetic mechanisms may be specific to GBM or non-GBM tumors.

## Study Design and Methods

### Study Design

This was a **two-sample Mendelian randomization (MR) study** that utilized a combined MR and colocalization approach. The primary goal was to infer causal relationships between genetically predicted gene expression levels (the exposure) and glioma risk (the outcome).

### Data Sources

* **Outcome GWAS Data (Glioma Risk):** Summary statistics were used from a large-scale glioma GWAS (7400 cases, 8257 controls), with subtype-specific analyses for glioblastoma (GBM, 3112 cases) and non-GBM gliomas (2411 cases).
* **Exposure eQTL Data (Gene Expression):** **Expression quantitative trait loci (eQTLs)** were sourced from two main sources:
    1.  **GTEx Data (Brain and Whole Blood):** eQTLs from **whole blood** (effective $n=31,684$) and **brain tissue** (estimated effective $n=1194$).
    2.  **Brain-Specific GTEx Data:** A more granular analysis was conducted using eQTLs from **13 distinct brain tissues** (e.g., cortex, cerebellum, amygdala) with smaller sample sizes ($n=114$ to 209).

### Statistical Analysis

1.  **Mendelian Randomization (MR):** The **Inverse-Variance Weighted (IVW) method** was used as the primary MR approach. This was complemented by robust sensitivity analyses, including:
    * **MR-Egger regression:** To test for and correct horizontal pleiotropy.
    * **Weighted Median and Weighted Mode:** To provide consistent causal estimates even if a subset of instruments are invalid.
    * **MR-PRESSO (Pleiotropy RESidual Sum and Outlier):** To detect and remove pleiotropic outliers.
2.  **Colocalization Analysis (moloc):** The **moloc** method was used to confirm that the observed association between gene expression and glioma risk was due to a **shared causal genetic variant**, rather than two separate causal variants in linkage disequilibrium. This analysis provided strong statistical evidence for a shared signal (posterior probability, $PP_4 > 0.8$).

## Conclusions and Recommendations

The study concludes that integrating multi-tissue eQTL data with robust MR and colocalization methods is effective for identifying biologically plausible, tissue-dependent genes involved in complex disease risk.

* The findings highlight the crucial role of **tissue specificity** in the genetic architecture of glioma, demonstrating that expression in the target tissue (brain) is often the most relevant exposure.
* The prioritization of genes like **RETREG2/FAM134A**, **FAM178B**, and **MVB12B** provides strong candidates for functional studies aimed at understanding the precise molecular mechanisms of glioma initiation and progression.
* The authors recommend that future genetic studies on brain disorders should prioritize the use of **brain-specific eQTL data** over more easily accessible (but less relevant) tissues like whole blood.